FDA Inspection
Re-Gen Active Lab IncRe-Gen Active Lab Inc – FDA Inspection, Jul 28, 2021
Record Details
This FDA Inspection record concerns Re-Gen Active Lab Inc, with an inspection on July 28, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Re-Gen Active Lab Inc
- Inspection Date
- July 28, 2021
- Product Type
- Biologics
View Company Profile
ID · 5e515cb4-157c-4cc1-aaf4-9321aa83eb58
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1147426
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Re-Gen Active Lab Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2023 | Not classified | Dallas District Office |
Other documents for Re-Gen Active Lab Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.